Melanoma Clinical Trials in Amsterdam
6 recruitingAmsterdam, Netherlands
Showing 1–6 of 6 trials
Recruiting
Phase 1
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Esophageal CancerGastric CancerCervical Cancer+5 more
Genentech, Inc.450 enrolled41 locationsNCT05581004
Recruiting
Phase 2
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Breast CancerEsophageal CancerGastric Cancer+11 more
Daiichi Sankyo740 enrolled84 locationsNCT06172478
Recruiting
Phase 1Phase 2
Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma
Melanoma
The Netherlands Cancer Institute96 enrolled6 locationsNCT06240143
Recruiting
Not Applicable
Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy
MelanomaOral CancerPenile Cancer
The Netherlands Cancer Institute29 enrolled1 locationNCT06666634
Recruiting
POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors
Melanoma
University Medical Center Groningen3,500 enrolled2 locationsNCT04193956
Recruiting
Phase 1Phase 2
Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion
MelanomaIn-Transit Metastasis
Vastra Gotaland Region74 enrolled4 locationsNCT03685890